News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
838,177 Results
Type
Article (75845)
Company Profile (727)
Press Release (761588)
Multimedia
Podcasts (180)
Webinars (28)
Section
Business (228042)
Career Advice (3739)
Deals (39442)
Drug Delivery (144)
Drug Development (89767)
Employer Resources (203)
FDA (18132)
Job Trends (17217)
News (389191)
Policy (38998)
Tag
Academia (3005)
Academic (1)
Accelerated approval (30)
Adcomms (35)
Allergies (136)
Alliances (56154)
ALS (174)
Alzheimer's disease (1764)
Antibody-drug conjugate (ADC) (315)
Approvals (18280)
Artificial intelligence (539)
Autoimmune disease (139)
Automation (33)
Bankruptcy (404)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (195)
Biotechnology (446)
Bladder cancer (154)
Brain cancer (62)
Breast cancer (629)
Cancer (4750)
Cardiovascular disease (416)
Career advice (3203)
Career pathing (40)
CAR-T (293)
CDC (59)
Celiac Disease (1)
Cell therapy (772)
Cervical cancer (37)
Clinical research (75470)
Collaboration (1631)
Company closure (4)
Compensation (1089)
Complete response letters (65)
COVID-19 (2982)
CRISPR (94)
C-suite (753)
Cystic fibrosis (148)
Data (5932)
Decentralized trials (2)
Denatured (65)
Depression (132)
Diabetes (500)
Diagnostics (7171)
Digital health (40)
Diversity (12)
Diversity, equity & inclusion (49)
Drug discovery (250)
Drug pricing (207)
Drug shortages (36)
Duchenne muscular dystrophy (227)
Earnings (97150)
Editorial (60)
Employer branding (25)
Employer resources (173)
Events (133475)
Executive appointments (1011)
FDA (21066)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (7)
Frontotemporal dementia (21)
Funding (1444)
Gene editing (204)
Generative AI (49)
Gene therapy (623)
GLP-1 (1091)
Government (5378)
Grass and pollen (8)
Guidances (380)
Healthcare (20921)
HIV (55)
Huntington's disease (45)
IgA nephropathy (80)
Immunology and inflammation (277)
Immuno-oncology (44)
Indications (79)
Infectious disease (3256)
Inflammatory bowel disease (199)
Inflation Reduction Act (16)
Influenza (114)
Intellectual property (223)
Interviews (731)
IPO (17872)
IRA (59)
Job creations (5000)
Job search strategy (2599)
Kidney cancer (16)
Labor market (88)
Layoffs (649)
Leadership (39)
Legal (9958)
Liver cancer (95)
Longevity (13)
Lung cancer (654)
Lymphoma (367)
Machine learning (39)
Management (66)
Manufacturing (754)
MASH (168)
Medical device (14955)
Medtech (14996)
Mergers & acquisitions (22565)
Metabolic disorders (1307)
Multiple sclerosis (152)
NASH (23)
Neurodegenerative disease (325)
Neuropsychiatric disorders (87)
Neuroscience (2980)
NextGen: Class of 2025 (7652)
Non-profit (5101)
Now hiring (62)
Obesity (628)
Opinion (327)
Ovarian cancer (156)
Pain (194)
Pancreatic cancer (210)
Parkinson's disease (276)
Partnered (33)
Patents (473)
Patient recruitment (428)
Peanut (59)
People (65446)
Pharmaceutical (135)
Pharmacy benefit managers (30)
Phase I (23347)
Phase II (32889)
Phase III (24822)
Pipeline (4091)
Policy (322)
Postmarket research (3260)
Preclinical (10301)
Press Release (72)
Prostate cancer (232)
Psychedelics (53)
Radiopharmaceuticals (291)
Rare diseases (824)
Real estate (7199)
Recruiting (80)
Regulatory (27959)
Reports (65)
Research institute (2714)
Resumes & cover letters (581)
Rett syndrome (24)
RNA editing (16)
RSV (82)
Schizophrenia (152)
Series A (244)
Series B (179)
Service/supplier (27)
Sickle cell disease (101)
Special edition (26)
Spinal muscular atrophy (173)
Sponsored (47)
Startups (4235)
State (2)
Stomach cancer (19)
Supply chain (108)
Tariffs (97)
The Weekly (113)
Vaccines (1111)
Venture capital (82)
Weight loss (439)
Women's health (77)
Worklife (21)
Date
Last 7 days (338)
Last 30 days (2274)
Last 365 days (32531)
2025 (32435)
2024 (37902)
2023 (42567)
2022 (53927)
2021 (58723)
2020 (57663)
2019 (51301)
2018 (39082)
2017 (36836)
2016 (37746)
2015 (43738)
2014 (38423)
2013 (34408)
2012 (36309)
2011 (36431)
2010 (35861)
Location
Africa (1209)
Alabama (86)
Alaska (7)
Arizona (307)
Arkansas (14)
Asia (50055)
Australia (8560)
California (10913)
Canada (3181)
China (1077)
Colorado (460)
Connecticut (481)
Delaware (327)
Europe (113011)
Florida (1598)
Georgia (354)
Hawaii (3)
Idaho (67)
Illinois (883)
India (61)
Indiana (526)
Iowa (22)
Japan (398)
Kansas (129)
Kentucky (41)
Louisiana (28)
Maine (81)
Maryland (1400)
Massachusetts (8073)
Michigan (336)
Minnesota (634)
Mississippi (6)
Missouri (135)
Montana (34)
Nebraska (28)
Nevada (118)
New Hampshire (80)
New Jersey (2978)
New Mexico (32)
New York (2912)
North Carolina (1535)
North Dakota (10)
Northern California (5162)
Ohio (329)
Oklahoma (22)
Oregon (50)
Pennsylvania (2209)
Puerto Rico (20)
Rhode Island (48)
South America (1570)
South Carolina (61)
South Dakota (1)
Southern California (4197)
Tennessee (168)
Texas (1708)
United States (39582)
Utah (326)
Vermont (1)
Virginia (273)
Washington D.C. (85)
Washington State (917)
West Virginia (4)
Wisconsin (113)
Wyoming (2)
838,177 Results for "chugai pharmaceutical co ltd japan".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Driven by a common vision, Mochida Pharmaceutical Co., Ltd. and Duchesnay Inc. sign a partnership to help address the issue of drug gap in Japan
December 15, 2025
·
3 min read
Press Releases
Hinge Bio Announces License and Collaboration with Kyorin Pharmaceutical Co., Ltd. for the Development and Commercialization of HB2198 in Japan for Autoimmune Diseases
October 1, 2025
·
6 min read
Press Releases
Rani Therapeutics Announces up to $1.085 Billion Collaboration with Chugai Pharmaceutical Co. for Multiple High-Value Therapeutics Including Rare Disease and Immunology Programs and Announces Concurrent Oversubscribed $60.3 Million Financing
October 20, 2025
·
7 min read
Artificial intelligence
Roche’s Chugai Breaks Into Aging via Potential $1B+ Deal With AI Outfit Gero
The partnership will give Chugai access to Gero’s artificial intelligence technology to discover novel targets in aging-related diseases. Chugai will then develop antibody-based drugs based on the findings.
July 7, 2025
·
2 min read
·
Dan Samorodnitsky
Press Releases
4DMT Announces Exclusive License Agreement with Otsuka Pharmaceutical Co., Ltd. for Development and Commercialization of 4D-150 in Asia-Pacific
October 31, 2025
·
8 min read
Press Releases
Nielsen BioSciences Announces Expanded CANDIN License Agreement with Maruho Co. Ltd.
October 24, 2025
·
3 min read
Press Releases
MEDIPOST Announces the Exclusive Commercialization License Agreement with Teikoku Seiyaku for Knee Osteoarthritis Treatment CARTISTEM® in Japan
December 19, 2025
·
3 min read
Press Releases
MEDIPAL HOLDINGS and JCR Pharmaceuticals Sign Global Licensing and Japan Co-Development Agreement for JR-479, a Novel Therapy for GM2 Gangliosidosis
September 3, 2025
·
6 min read
Press Releases
Faron Pharmaceuticals Ltd: Holding(s) in Company
December 5, 2025
·
3 min read
Press Releases
KalVista Pharmaceuticals Announces Approval of EKTERLY® (sebetralstat) in Japan, First and Only Oral On-demand Treatment for Hereditary Angioedema
December 23, 2025
·
5 min read
1 of 83,818
Next
